DMA Diamedica Therapeutics

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its 2018 financial results will be released after market close on Tuesday, March 19th.  DiaMedica’s management will host a live conference call on Wednesday, March 20th at 8:00am Central Time to provide a business update and discuss the Company’s financial results.

Conference Call details:

Date:	March 20, 2019
Time:	8:00 AM CT
Web access:	https://edge.media-server.com/m6/p/idbwv4bq
Dial In:	(866) 962-3593 (domestic)
	(630) 652-5857 (international)
Conference ID:	6773627

Listeners should log on to the website or dial in 15 minutes prior to the call.  The webcast will remain available for play back on our website, under investor events and presentations, following the earnings call and for 12 months thereafter. A telephonic replay of the conference call will be available until March 28, 2019, by dialing 1(855) 859-2056 (US Toll Free Dial In), (404) 537-3406 (international), replay passcode 6773627.

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. The Company currently has an ongoing phase II study in acute ischemic stroke and a phase Ib study in chronic kidney disease. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.”

For more information, please visit www.diamedica.com.

Contact:

Scott KellenChief Financial OfficerPhone: (763) 496-5118 skellen@diamedica.com

Paul Papi Vice President of Business Development Phone: (617) 899-5941info@diamedica.com